|
Yang, S; Kittlesen, D; Slingluff Jr, C L et al. (2000) Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. J Immunol 164:4204-11
|
|
Yang, S; Vervaert, C E; Seigler, H F et al. (1999) Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor. Gene Ther 6:253-62
|
|
Dong, X D; Abdel-Wahab, Z; Dematos, P et al. (1999) MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases. J Surg Oncol 71:36-45
|
|
Abdel-Wahab, Z; DeMatos, P; Hester, D et al. (1998) Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity. Cell Immunol 186:63-74
|
|
DeMatos, P; Abdel-Wahab, Z; Vervaert, C et al. (1998) Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice. J Surg Oncol 68:79-91
|
|
DeMatos, P; Abdel-Wahab, Z; Vervaert, C et al. (1998) Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice. Cell Immunol 185:65-74
|
|
Yang, S; Darrow, T L; Seigler, H F (1997) Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res 57:1561-8
|
|
Abdel-Wahab, Z; Dar, M; Osanto, S et al. (1997) Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon. Cancer Gene Ther 4:33-41
|
|
Yang, S; Darrow, T L; Vervaert, C E et al. (1997) Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Cell Immunol 179:84-95
|
|
Abdel-Wahab, Z; Weltz, C; Hester, D et al. (1997) A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response. Cancer 80:401-12
|
Showing the most recent 10 out of 11 publications
